Nupercainal

Name: Nupercainal

Nupercainal Drug Class

Nupercainal is part of the drug classes:

  • Amides

  • Analgesics and anesthetics

  • Anesthetics for topical use

What is Nupercainal (dibucaine topical)?

Dibucaine is an anesthetic, or numbing medicine.

Dibucaine topical (for the skin) is used to treat minor pain and itching caused by burns, insect bites, sunburn, or other skin irritations. Dibucaine topical is also used to relieve rectal pain and itching caused by hemorrhoids or other rectal irritations.

Dibucaine topical may also be used for purposes not listed in this medication guide.

What happens if I overdose?

An overdose of dibucaine topical is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medication.

What should I avoid while using Nupercainal (dibucaine topical)?

Do not apply this medicine near your eyes. Rinse with water if the medicine gets in your eyes.

Avoid exposure to sunlight or tanning beds. Dibucaine topical can make you sunburn more easily. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.

Uses for Nupercainal

Dermatologic Conditions

Self-medication for temporary relief of pain and itching associated with minor burns, sunburn, minor cuts or scrapes, insect bites, or minor skin irritations.a c

Hemorrhoids

Self-medication for temporary relief of pain, itching, and burning caused by hemorrhoids.a c

Stability

Storage

Topical

Ointment

Tight, light-resistant containers at <40°C, preferably between 15–30°C.a c

Advice to Patients

  • Importance of discontinuing therapy and consulting clinician if a rash or irritation develops during therapy.a c

  • Importance of washing hands following administration.c

  • Importance of avoiding contact with the eyes.a c

  • Importance of using as directed and not applying in large quantities, particularly over raw surfaces or blistered areas.a

  • Importance of discontinuing therapy and consulting clinician if dermatologic condition worsens or symptoms persist for >7 days or if redness, irritation, or bleeding occurs.a c

  • Importance of women informing their clinician if they are or plan to become pregnant or plan to breast-feed.c

  • Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as any concomitant illnesses.c

  • Importance of informing patients of other important precautionary information. (See Cautions.)

Commonly used brand name(s)

In the U.S.

  • Nupercainal

Available Dosage Forms:

  • Cream
  • Ointment

Therapeutic Class: Anesthetic, Local

Chemical Class: Amino Amide

What do I need to tell my doctor BEFORE I take Nupercainal?

  • If you have an allergy to dibucaine or any other part of Nupercainal (dibucaine rectal ointment).
  • If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.

This medicine may interact with other drugs or health problems.

Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this medicine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.

What are some other side effects of Nupercainal?

All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if you have any side effects that bother you or do not go away.

These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch.

(web3)